July 4, 2012 – Recent reports indicate that Boehringer Ingelheim, the company who manufactures the popular anticoagulant Pradaxa, is now working to develop an antidote that will stop internal bleeding issues which have plagued the drug so far.
The move follows warnings by the FDA, European Medicines Agency and Institute for Safe Medication Practices that Pradaxa could cause irreversible internal bleeding attacks, as well as the filing of multiple lawsuits over serious injury and death.
If you or a loved one have been affected by Pradaxa bleeding, contact us today to speak with a lawyer about your legal rights as soon as possible.
Pradaxa is an anticoagulant medication which is prescribed to many patients suffering from atrial fibrillation in order to prevent strokes. It is now considered a blockbuster drug after selling more than $1 billion in the year ending February, 2012.
Last December, the FDA warned about the safety of Pradaxa after they received abnormally high reports of injury or death. On May 25th, the European Medicines Agency also issued a warning on internal bleeding risks.
In June, the Institute for Safe Medication Practices reported that Pradaxa led all other medications in 2011 for the number of deaths and internal bleeding episodes reported to the FDA.
Although all anticoagulant drugs have a risk of causing internal bleeding, most have a reversal agent that doctors can use in emergency. In March, the Journal of Neurosurgery highlighted concerns from doctors that once Pradaxa causes internal bleeding in a patient, there is little they can do to stop it.
However, Reuters recently reported Boehringer Ingelheim is working at developing an antidote to the internal bleeding problems. Many believe this is due to the mounting lawsuits from victims.
Victims of Pradaxa bleeding around the country recently asked that all Pradaxa lawsuits be relocated to one central federal court. In the request, lawyers state they expect as many as 500 cases will be filed.
If you have been affected by Pradaxa side effects, you should speak with a lawyer as soon as possible. Since these federal MDL cases are unique, only certain lawyers can help. The Pradaxa Resource center works only with qualified lawyers who are already filing these cases.
For more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, contact us today.